Res 2016-077/approving an administrative services agreement with United Healthcare Services, Inc. for the provision of medical, pharmacy, dental, flexible spending accounts (fsa), retiree, online enrollment tool and cobra benefits administration in a tot

Home Browse Search

GAUCHERS DISEASE CERDELGA 13.5% MULTIPLE SCLEROSIS COPAXONE 13.5% GROWTH HORMONE DEFICIENCY GENOTROPIN 13.9% MULTIPLE SCLEROSIS EXTAVIA 12.6% GROWTH HORMONE DEFICIENCY HUMATROPE 14.2% MULTIPLE SCLEROSIS GILENYA 13.5% GROWTH HORMONE DEFICIENCY INCRELEX 12.6% MULTIPLE SCLEROSIS GLATOPA 13.5% GROWTH HORMONE DEFICIENCY NORDITROPIN 14.2% MULTIPLE SCLEROSIS PLEGRIDY 13.5% GROWTH HORMONE DEFICIENCY NUTROPIN 13.2% MULTIPLE SCLEROSIS REBIF 13.3% GROWTH HORMONE DEFICIENCY NUTROPIN AQ 12.4% MULTIPLE SCLEROSIS REBIF REBIDOSE 13.3% GROWTH HORMONE DEFICIENCY NUTROPIN AQ NUSPIN 12.4% MULTIPLE SCLEROSIS TECFIDERA 13.5% GROWTH HORMONE DEFICIENCY OMNITROPE 13.8% NEUTROPENIA LEUKINE 13.7% GROWTH HORMONE DEFICIENCY SAIZEN 16.2% NEUTROPENIA NEULASTA 13.5% GROWTH HORMONE DEFICIENCY SEROSTIM 11.2% NEUTROPENIA NEUPOGEN 13.5% GROWTH HORMONE DEFICIENCY TEV -TROPIN 14.2% NEUTROPENIA ZARXIO 13.5% GROWTH HORMONE DEFICIENCY ZOMACTON 13.2% ONCOLOGY- INJECTABLE INTRON A 13.0% GROWTH HORMONE DEFICIENCY ZORBTIVE 13.0% ONCOLOGY- INJECTABLE SYLATRON 13.5% HEMATOLOGIC BERINERT 5.5% ONCOLOGY - INJECTABLE SYNRIBO 11.4% HEMATOLOGIC CINRYZE 7.8% ONCOLOGY - ORAL AFINITOR 12.6% HEMATOLOGIC FIRAZYR 13.5% ONCOLOGY-ORAL AFINITOR DISPERZ 12.6% HEMATOLOGIC MOZOBIL 12.6% ONCOLOGY - ORAL BEXAROTENE 13.5% HEMATOLOGIC PROMACTA 12.6% ONCOLOGY-ORAL BOSULIF 13.5% HEMATOLOGIC RUCONEST 12.5% ONCOLOGY-ORAL CAPECITABINE 13.2% HEMOPHILIA ADVATE 38.7% ONCOLOGY - ORAL CAPRELSA 8.3% HEMOPHILIA ALPHANATE /VON WILLEBRAND 36.8% ONCOLOGY - ORAL COMETRIQ 10.6% HEMOPHILIA ALPHANINE SD 30.5% ONCOLOGY-ORAL ERIVEDGE 12.5% HEMOPHILIA ALPROLIX 13.5% ONCOLOGY - ORAL FARYDAK 13.5% HEMOPHILIA BEBULIN 12.7% ONCOLOGY - ORAL GILOTRIF 13.5% HEMOPHILIA BENEFIX 7.3% ONCOLOGY - ORAL GLEEVEC 14.2% HEMOPHILIA CORIFACT 13.5% ONCOLOGY - ORAL HYCAMTIN 14.8% HEMOPHILIA ELOCTATE 24.8% ONCOLOGY-ORAL IBRANCE 13.5% HEMOPHILIA FEIBA 31.1% ONCOLOGY-ORAL ICLUSIG 12.5% HEMOPHILIA FEIBA NF 31.1% ONCOLOGY - ORAL IMBRUVICA 13.5% HEMOPHILIA FEIBA VH IMMUNO 31.1% ONCOLOGY - ORAL INLYTA 13.5% HEMOPHILIA HELIXATE FS 36.9% ONCOLOGY-ORAL IRESSA 13.5% HEMOPHILIA HEMOFIL M 40.9% ONCOLOGY - ORAL JAKAFI 12.5% HEMOPHILIA HUMATE -P 24.3% ONCOLOGY - ORAL LENVIMA 13.5% HEMOPHILIA IXINITY 7.3% ONCOLOGY - ORAL LONSURF 14.5% HEMOPHILIA KOATE -DVI 40.9% ONCOLOGY - ORAL LYNPARZA 11.9% HEMOPHILIA KOGENATE FS 39.9% ONCOLOGY - ORAL MATULANE 12.5% HEMOPHILIA MONOCLATE -P 29.6% ONCOLOGY - ORAL MEKINIST 11.4% 40